In much of Africa, the infrastructure to support scientific research is sorely lacking. But Chibale is working to change that. The Zambian chemist has built H3D, Africa’s first integrated drug discovery center, at the University of Cape Town. His team now includes more than 90 researchers; they work out of state-of-the-art facilities thanks to partnerships with the Gates Foundation, Novartis, and South Africa’s government. H3D already has a potential drug for malaria in human trials.